Whether reduction of monocyte chemotactic protein-1 and hepcidin mRNA expression are hematopoiesis-independent effects of HIF-PH inhibition or result from the correction of anemia cannot be determined based on the current data. The gene discussed is CCL2; the disease is anemia.